TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 7 | 0 | 0 | -3 | 5 | 4 | 7 | 2 |
| S | %wins | 57 | 29 | 71 | 57 | 43 | 57 | 52 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/14 17:48 | 4/28/14 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | Acting C | S | -228 | 110.45 | 33 | -2 | -5 | 41 | D | 69 | 5 | -3 | -5 | -10 | -6 | -4 | -2 | 0 | 1 | 4 | 10 | 33 | 48 |
1/27/10 20:43 | 1/26/10 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Finan | M.d | 1,654 | 52.98 | 33 | 31 | 13 | D | 18 | 4 | -7 | 1 | 0 | -1 | 1 | 0 | 1 | 3 | -3 | 0 | -6 | -1 | |
1/27/10 20:43 | 1/26/10 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Finan | S.d | -1,759 | 56.34 | 33 | -31 | -71 | 13 | D | 18 | 4 | -7 | 1 | 0 | -1 | 1 | 0 | 1 | 3 | -3 | 0 | -6 | -1 |
2/18/09 17:05 | 10/29/08 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Finan | S.a | -103 | 60.17 | 33 | -2 | -13 | 11 | B | -1 | -1 | -12 | -14 | 4 | 0 | ||||||||
10/30/08 15:10 | 10/29/08 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Finan | S | -103 | 60.17 | 33 | -2 | -13 | 11 | D | -22 | 3 | 36 | -6 | -2 | 17 | 10 | 3 | 3 | 1 | -6 | -7 | -17 | -8 |
5/28/08 18:50 | 5/27/08 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Finan | S | -216 | 43.17 | 33 | -5 | -27 | 14 | D | -37 | -21 | -20 | -10 | -1 | 0 | 2 | 2 | 1 | 3 | 9 | 49 | 28 | 16 |
12/10/07 14:34 | 12/7/07 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Finan | S | -363 | 52.50 | 33 | -7 | -36 | 13 | D | -35 | -25 | -9 | 2 | -9 | -6 | -5 | -5 | -2 | -7 | -9 | -14 | -16 | 12 |
7/27/06 16:23 | 7/27/06 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Michael A Kelly | CA | O | VP Corp | S | -52 | 69.33 | 33 | -1 | -17 | 4 | D | 25 | -15 | -8 | 5 | 3 | 6 | 8 | 5 | 0 | 2 | -3 | 8 | 3 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |